Akso Health (AHG) Liabilities and Shareholders Equity (2017 - 2026)

Akso Health (AHG) has 10 years of Liabilities and Shareholders Equity data on file, last reported at $189.6 million in Q1 2026.

• Quarterly Liabilities and Shareholders Equity fell 11.78% year-over-year to $189.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $829.6 million (up 41.37% YoY) and the FY2026 annual result came in at $189.6 million, down 11.78% from the prior year.
• Liabilities and Shareholders Equity retreated to $189.6 million in Q1 2026, from $212.0 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $215.0 million in Q1 2025 to a low of $16.9 million in Q3 2023.
• A 5-year average of $121.4 million and a median of $142.0 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity jumped 64281681.64% — and 2023, when it slumped 67.42%.
• Tracing AHG's Liabilities and Shareholders Equity over 5 years: stood at $20.9 million in 2022, then fell by 19.26% to $16.9 million in 2023, then jumped by 1161.51% to $212.9 million in 2024, then decreased by 0.43% to $212.0 million in 2025, then slipped by 10.57% to $189.6 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $189.6 million (Q1 2026), $212.0 million (Q3 2025), and $215.0 million (Q1 2025), per Business Quant data.